Select your timezone:
Room: C5

324.4 Pre-emptive intestinal transplant: PRO

Kishore Iyer, United States

Professor of Surgery & Pediatrics, Director, Intestinal Rehab & Transplant
Recanati miller Transplant Institute
MOUNT SINAI HOSPITAL/ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Biography

Kishore Iyer is Director of the Adult and Pediatric Intestinal Rehabilitation & Transplantation Program at Mount Sinai Medical Center in New York, and a Professor of Transplant Surgery and Pediatrics at the Icahn School of Medicine at Mount Sinai in New York.  Kishore is a Fellow of the Royal College of Surgeons of England and a Fellow of the American College of Surgeons.  Kishore has an international reputation for deep expertise in all aspects of intestinal failure, complex gastro-intestinal and re-operative surgery as well as pediatric hepatobiliary surgery. Kishore trained in general and pediatric surgery in the UK where he worked with Dr Adrian Bianchi and developed his early interest in short bowel syndrome and the use of intestinal lengthening procedures.  His research at the Great Ormond Street Hospital for Sick Children and Institute of Child Health in London, won the 1996 British Association of Pediatric Surgeons International Prize for his pioneering work identifying phytosterols in soy-based lipid emulsions as a potential cause for intestinal failure-associated liver disease. Kishore trained in transplant surgery at Chicago and Omaha and was responsible for establishing and directing the intestinal rehabilitation program in Omaha, the first of its kind nationally. Kishore’s current clinical and research interests are in the broad areas of intestinal failure and transplant as well as drug development for intestinal failure. He is currently the international Principal Investigator for a large multi-center, multi-national Phase 3 Trial of Apraglutide in Short Bowel Syndrome related Intestinal Failure. In 2019 Kishore launched a virtual tele-learning program in intestinal failure, the Learn Intestinal Failure-TeleECHO Program (LIFT-ECHO); see www.liftecho.org. The weekly program attracts an average of 130 participating sites signing in to each session from over 42 US states and over 40 countries. The preliminary reports from this exciting project suggest that tele-learning can help improve outcomes in rare diseases by ‘moving knowledge not people’. Kishore is currently pursuing an Executive MSc in Evaluation of Healthcare interventions and outcomes at the London School of Economics (Class of 2023). When not involved with intestinal failure, Kishore is a politics-junkie, has a very eclectic taste in music and remains an avid motorcyclist.

Social Media Promotion Image

right-click to download

© 2024 TTS 2022